The Microbiome and Human Obesity: Wait a Minute

Posted by: | May 26, 2023 | Comments

In the pipeline: Derek Lowe’s commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine.

For the last few years, it has been impossible to escape talk of the microbiome – the associated bacteria (and other organisms) that live in and on the human body. Overall, this attention has been a good thing, since it’s made people aware of just how bacteria-laden we are (not that everyone finds that a comfortable subject). And in some cases, particularly Irritable Bowel Syndrome, evidence is accumulating that microflora are a big part of the disease state, and might be a big part of treatment as well. It’s been known for a long time that antibiotic treatment can disrupt the gut biota, of course, with a particular case being C. difficile colitis. But it’s quite plausible that less dramatic changes in bacterial populations could also have noticeable effects.

Read more at: Science Translational Medicine






Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required



Terms & Conditions | Privacy Policy | © 2016 The Translational Microbiome Research Forum